Ceftazidime Injection, Powder, For Solution
Product Images NDC 44567-235

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ceftazidime (NDC 44567-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wg Critical Care, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of Ceftazidime, including its molecular components and a hydration state indicated by 5 molecules of water (pentahydrate).*

FDA Label Image

Ceftazidime For Injection, Usp 1 G/vial Label Imiage (Image 02)

Label for Ceftazidime for Injection, USP 1 gram per vial, a powder for solution injection for intravenous or intramuscular use. The single-dose vial contains 1 gram of anhydrous ceftazidime. Manufactured by WG Critical Care, LLC, Paramus, NJ. The label includes NDC 44567-235-25 and indicates Rx only.*

FDA Label Image

Ceftazidime For Injection, Usp 2 G/vial Label Image (Image 03)

Ceftazidime for Injection, USP 2 grams per vial powder for solution, single-dose vial for intravenous use. Manufactured by WG Critical Care, LLC. The label includes NDC 44567-236-10 and indicates the vial contains 2 grams equivalent to 2 g of anhydrous ceftazidime. It is Rx only and provides detailed excipient and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.